Shahnawaz Ali Bhat - Neuroscience - Best Researcher Award
Aligarh Muslim University - India
AUTHOR PROFILE
🧠EXPERT IN THERAPEUTIC PEPTIDES AND HUNTINGTON’S DISEASE
Shahnawaz Ali Bhat, an esteemed researcher at Aligarh Muslim University, is dedicated to the field of molecular neuroscience. His work focuses on unraveling the complex interactions of therapeutic peptides, which offer significant potential in the treatment of Huntington’s disease. With a passion for finding innovative solutions to neurodegenerative disorders, his research is at the cutting edge of therapeutic development, exploring how these peptides can change the landscape of future treatments.
🔬 INVESTIGATING MITOCHONDRIAL STRUCTURE AND FUNCTION
In his role as an editorial leader, Shahnawaz has contributed extensively to understanding the proteins and protein complexes that influence mitochondrial structure and function. His editorial work on these topics delves into how mitochondrial dysfunction can lead to various diseases, offering insights into potential therapeutic interventions. This research is crucial for developing treatments for diseases linked to metabolic and structural mitochondrial abnormalities.
🌿 RESEARCHING WITHANIA SOMNIFERA (ASHWAGANDHA) FOR THERAPEUTIC POTENTIAL
Shahnawaz has a keen interest in the therapeutic properties of traditional medicines, particularly the molecular targets of Withania somnifera (Ashwagandha). His editorial contributions explore the potential of this ancient herb in treating a wide range of pathological conditions. By investigating its molecular interactions, he aims to uncover its role in modern medical applications, offering a bridge between traditional and contemporary medicine.
🧬 ADVANCING KNOWLEDGE IN PROTEIN COMPLEXES AND DISEASES
With a focus on the intricate relationships between proteins and diseases, Shahnawaz’s research explores how protein complexes influence disease progression. His work is aimed at unlocking the therapeutic potential of proteins, particularly in conditions like Huntington’s disease and other neurodegenerative disorders. His expertise in protein structures has made him a vital contributor to understanding how these biological systems can be manipulated for better health outcomes.
đź’ˇ BRIDGING MOLECULAR BIOLOGY AND THERAPEUTIC SOLUTIONS
Shahnawaz’s interdisciplinary approach combines molecular biology with therapeutic innovation. His research bridges the gap between understanding molecular mechanisms and developing practical solutions for treating complex diseases. By focusing on the underlying molecular pathways, he has contributed to a deeper understanding of how diseases can be effectively targeted and treated.
đź“– EDITORIAL CONTRIBUTIONS TO SCIENTIFIC ADVANCEMENTS
As an editorial figure in several prestigious publications, Shahnawaz plays a crucial role in guiding scientific discussions in his field. His editorial work includes topics related to proteins, mitochondrial function, and therapeutic approaches, ensuring that cutting-edge research reaches a broad audience. His editorial influence extends the impact of his own research while fostering collaboration among scientists worldwide.
🌍 COMMITTED TO ADVANCING GLOBAL HEALTH
Driven by a commitment to improving global health outcomes, Shahnawaz Ali Bhat’s research and editorial contributions have a far-reaching impact. Whether investigating therapeutic peptides for neurodegenerative diseases or exploring the ancient wisdom of herbal medicines like Withania somnifera, his work is centered on enhancing human health. His contributions continue to shape the future of medical research and therapeutic development.
NOTABLE PUBLICATION
Title: The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease
Authors: Bhat, S.A., Ahamad, S., Dar, N.J., Siddique, Y.H., Nazir, A.
Journal: Current Neuropharmacology
Year: 2023
Title: The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease
Authors: Ahamad, S., Bhat, S.A.
Journal: Journal of Medicinal Chemistry
Year: 2022
Title: Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment
Authors: Ahamad, S., Bhat, S.A.
Journal: Journal of Medicinal Chemistry
Year: 2022
Title: Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases
Authors: Chopra, G., Shabir, S., Yousuf, S., Mir, A.H., Singh, M.P.
Journal: Molecular Neurobiology
Year: 2022
Title: Structure elucidation of a bimetallic ÎĽ-hydroxo-bridged Cu(II)-flufenamate-bpy complex and cytotoxic evaluation against MDA-MB-231 and A549 carcinoma cell lines
Authors: Yousuf, I., Mantoo, I.A., Bashir, M., Bhat, S.A.
Journal: Applied Organometallic Chemistry
Year: 2022